Clinical Trial Results:
Et fase II forsøg med Tarceva (erlotinib) og en undersøgelse af prædiktive markører ved første-line behandling af avanceret ikke-småcellet lungecancer hos patienter, der ikke er egnede til behandling med kemoterapi
Summary
|
|
EudraCT number |
2006-003420-10 |
Trial protocol |
DK |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Jun 2021
|
First version publication date |
14 Jun 2021
|
Other versions |
|
Summary report(s) |
Study report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.